BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ibrahim A, Ali RAR, Manaf MRA, Ahmad N, Tajurruddin FW, Qin WZ, Desa SHM, Ibrahim NM. Multi-strain probiotics (Hexbio) containing MCP BCMC strains improved constipation and gut motility in Parkinson's disease: A randomised controlled trial. PLoS One 2020;15:e0244680. [PMID: 33382780 DOI: 10.1371/journal.pone.0244680] [Cited by in Crossref: 4] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Hong CT, Chen JH, Huang TW. Probiotics treatment for Parkinson disease: a systematic review and meta-analysis of clinical trials. Aging (Albany NY) 2022;14. [PMID: 36084951 DOI: 10.18632/aging.204266] [Reference Citation Analysis]
2 Brunelli L, De Vitis V, Ferrari R, Minuzzo M, Fiore W, Jäger R, Taverniti V, Guglielmetti S. In vitro assessment of the probiotic properties of an industrial preparation containing Lacticaseibacillus paracasei in the context of athlete health. Front Pharmacol 2022;13:857987. [DOI: 10.3389/fphar.2022.857987] [Reference Citation Analysis]
3 Thangaleela S, Sivamaruthi BS, Kesika P, Bharathi M, Chaiyasut C. Role of the Gut–Brain Axis, Gut Microbial Composition, Diet, and Probiotic Intervention in Parkinson’s Disease. Microorganisms 2022;10:1544. [DOI: 10.3390/microorganisms10081544] [Reference Citation Analysis]
4 Sun X, Xue L, Wang Z, Xie A. Update to the Treatment of Parkinson's Disease Based on the Gut-Brain Axis Mechanism. Front Neurosci 2022;16:878239. [PMID: 35873830 DOI: 10.3389/fnins.2022.878239] [Reference Citation Analysis]
5 Skowron K, Budzyńska A, Wiktorczyk-Kapischke N, Chomacka K, Grudlewska-Buda K, Wilk M, Wałecka-Zacharska E, Andrzejewska M, Gospodarek-Komkowska E. The Role of Psychobiotics in Supporting the Treatment of Disturbances in the Functioning of the Nervous System-A Systematic Review. Int J Mol Sci 2022;23:7820. [PMID: 35887166 DOI: 10.3390/ijms23147820] [Reference Citation Analysis]
6 Fan HX, Sheng S, Zhang F. New hope for Parkinson's disease treatment: Targeting gut microbiota. CNS Neurosci Ther 2022. [PMID: 35822696 DOI: 10.1111/cns.13916] [Reference Citation Analysis]
7 Cabanillas-Lazo M, Quispe-Vicuña C, Barja-Ore J, Fernandez-Giusti A, Munive-Degregori A, Retamozo-Siancas Y, Guerrero ME, Mayta-Tovalino F. A 10-Year Bibliometric Analysis of Global Research on Gut Microbiota and Parkinson's Disease: Characteristics, Impact, and Trends. Biomed Res Int 2022;2022:4144781. [PMID: 35795315 DOI: 10.1155/2022/4144781] [Reference Citation Analysis]
8 Zhu M, Liu X, Ye Y, Yan X, Cheng Y, Zhao L, Chen F, Ling Z. Gut Microbiota: A Novel Therapeutic Target for Parkinson’s Disease. Front Immunol 2022;13:937555. [DOI: 10.3389/fimmu.2022.937555] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Xu J, Wang L, Chen X, Le W. New Understanding on the Pathophysiology and Treatment of Constipation in Parkinson’s Disease. Front Aging Neurosci 2022;14:917499. [DOI: 10.3389/fnagi.2022.917499] [Reference Citation Analysis]
10 Wang Y, Li L, Zhao X, Sui S, Wang Q, Shi G, Xu H, Zhang X, He Y, Gu J. Intestinal Microflora Changes in Patients with Mild Alzheimer's Disease in a Chinese Cohort. J Alzheimers Dis 2022. [PMID: 35662119 DOI: 10.3233/JAD-220076] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Pavan S, Prabhu AN, Prasad Gorthi S, Das B, Mutreja A, Shetty V, Ramamurthy T, Ballal M. Exploring the multifactorial aspects of Gut Microbiome in Parkinson's Disease. Folia Microbiol (Praha) 2022. [PMID: 35583791 DOI: 10.1007/s12223-022-00977-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Alviz-Gazitua P, González A, Lee MR, Aranda CP. Molecular Relationships in Biofilm Formation and the Biosynthesis of Exoproducts in Pseudoalteromonas spp. Mar Biotechnol (NY) 2022. [PMID: 35486299 DOI: 10.1007/s10126-022-10097-0] [Reference Citation Analysis]
13 Lau YH, Podlewska A, Ocloo J, Gupta A, Gonde C, Bloem BR, Chaudhuri KR. Does Ethnicity Influence Recruitment into Clinical Trials of Parkinson's Disease? J Parkinsons Dis 2022;12:975-81. [PMID: 35068418 DOI: 10.3233/JPD-213113] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Korf JM, Ganesh BP, Mccullough LD. Gut dysbiosis and age-related neurological diseases in females. Neurobiology of Disease 2022;168:105695. [DOI: 10.1016/j.nbd.2022.105695] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
15 Wang L, Zhao Z, Zhao L, Zhao Y, Yang G, Wang C, Gao L, Niu C, Li S. Lactobacillus plantarum DP189 Reduces α-SYN Aggravation in MPTP-Induced Parkinson’s Disease Mice via Regulating Oxidative Damage, Inflammation, and Gut Microbiota Disorder. J Agric Food Chem . [DOI: 10.1021/acs.jafc.1c07711] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
16 Klann EM, Dissanayake U, Gurrala A, Farrer M, Shukla AW, Ramirez-zamora A, Mai V, Vedam-mai V. The Gut–Brain Axis and Its Relation to Parkinson’s Disease: A Review. Front Aging Neurosci 2022;13:782082. [DOI: 10.3389/fnagi.2021.782082] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
17 Yang T, Liu Y, Li J, Xu H, Li S, Xiong L, Wang T. Advances in clinical basic research: Performance, treatments, and mechanisms of Parkinson disease. Ibrain 2021;7:362-78. [DOI: 10.1002/ibra.12011] [Reference Citation Analysis]
18 Sun N, Xue Y, Wei S, Wu B, Wang H, Zeng D, Zhao Y, Khalique A, Pan K, Zeng Y, Shu G, Jing B, Ni X. Compound Probiotics Improve Body Growth Performance by Enhancing Intestinal Development of Broilers with Subclinical Necrotic Enteritis. Probiotics Antimicrob Proteins 2021. [PMID: 34735679 DOI: 10.1007/s12602-021-09867-4] [Reference Citation Analysis]
19 Youssef M, Ahmed HY, Zongo A, Korin A, Zhan F, Hady E, Umair M, Shahid Riaz Rajoka M, Xiong Y, Li B. Probiotic Supplements: Their Strategies in the Therapeutic and Prophylactic of Human Life-Threatening Diseases. Int J Mol Sci 2021;22:11290. [PMID: 34681948 DOI: 10.3390/ijms222011290] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Hasain Z, Che Roos NA, Rahmat F, Mustapa M, Raja Ali RA, Mokhtar NM. Diet and Pre-Intervention Washout Modifies the Effects of Probiotics on Gestational Diabetes Mellitus: A Comprehensive Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients 2021;13:3045. [PMID: 34578921 DOI: 10.3390/nu13093045] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
21 Socała K, Doboszewska U, Szopa A, Serefko A, Włodarczyk M, Zielińska A, Poleszak E, Fichna J, Wlaź P. The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders. Pharmacol Res 2021;172:105840. [PMID: 34450312 DOI: 10.1016/j.phrs.2021.105840] [Cited by in Crossref: 1] [Cited by in F6Publishing: 20] [Article Influence: 1.0] [Reference Citation Analysis]
22 Mirzaei H, Sedighi S, Kouchaki E, Barati E, Dadgostar E, Aschner M, Tamtaji OR. Probiotics and the Treatment of Parkinson's Disease: An Update. Cell Mol Neurobiol 2021. [PMID: 34283340 DOI: 10.1007/s10571-021-01128-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]